Covered recipient · General Payments record
LISA Y YEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$4,728.81
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,915.12 | 8 |
| Honoraria | $1,225.00 | 1 |
| Food and Beverage | $765.09 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $3,741.98 | 15 |
| TerSera Therapeutics LLC | $140.25 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $22.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | $22.98 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092705176 | CMS |
| Exelixis Inc. | $55.38 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138572539 | CMS |
| Exelixis Inc. | $528.95 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572541 | CMS |
| Exelixis Inc. | $175.00 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572543 | CMS |
| Exelixis Inc. | $215.46 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572545 | CMS |
| Exelixis Inc. | $155.55 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138572547 | CMS |
| Exelixis Inc. | $90.00 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138572549 | CMS |
| Exelixis Inc. | $38.15 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572551 | CMS |
| Exelixis Inc. | $528.95 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572555 | CMS |
| Exelixis Inc. | $55.38 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138572557 | CMS |
| Exelixis Inc. | $38.15 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572559 | CMS |
| Exelixis Inc. | $215.46 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572561 | CMS |
| Exelixis Inc. | $175.00 | 06/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1138572563 | CMS |
| Exelixis Inc. | $155.55 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138572565 | CMS |
| Exelixis Inc. | $90.00 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138572567 | CMS |
| Exelixis Inc. | $1,225.00 | 07/03/2024 | Honoraria | Undisputed | 01/23/2026 | 1138572553 | CMS |
| TerSera Therapeutics LLC | $140.25 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144722523 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.